Pages that link to "Q35839898"
Jump to navigation
Jump to search
The following pages link to Prognostic significance of host immune gene polymorphisms in follicular lymphoma survival (Q35839898):
Displaying 50 items.
- Polymorphisms in DNA repair and one-carbon metabolism genes and overall survival in diffuse large B-cell lymphoma and follicular lymphoma (Q24630661) (← links)
- Risk of non-Hodgkin lymphoma in association with germline variation in complement genes (Q24648778) (← links)
- Identification of predictive pathways for non-hodgkin lymphoma prognosis (Q30497902) (← links)
- Inherited genetic variation and overall survival following follicular lymphoma (Q30519549) (← links)
- NCC-AUC: an AUC optimization method to identify multi-biomarker panel for cancer prognosis from genomic and clinical data (Q30975484) (← links)
- Identification of non-Hodgkin's lymphoma prognosis signatures using the CTGDR method. (Q33551799) (← links)
- Nature and importance of follicular lymphoma precursors (Q33558757) (← links)
- Cytokine gene polymorphisms and progression-free survival in classical Hodgkin lymphoma by EBV status: results from two independent cohorts. (Q33598099) (← links)
- Inherited determinants of ovarian cancer survival (Q33638923) (← links)
- A multiplex MALDI-TOF MS approach facilitates genotyping of DNA from formalin-fixed paraffin-embedded tumour specimens (Q33677062) (← links)
- Active idiotypic vaccination versus control immunotherapy for follicular lymphoma (Q33691505) (← links)
- Survival prediction based on inherited gene variation analysis (Q33745031) (← links)
- Bayesian ensemble methods for survival prediction in gene expression data (Q33767777) (← links)
- Smoking, alcohol use, obesity, and overall survival from non-Hodgkin lymphoma: a population-based study (Q33930843) (← links)
- The associations between immunity-related genes and breast cancer prognosis in Korean women (Q33975510) (← links)
- Recent advances in the treatment of B-cell lymphoma (Q34062432) (← links)
- IL-4 protein expression and basal activation of Erk in vivo in follicular lymphoma (Q34198061) (← links)
- SNP rs6457327 in the HLA region on chromosome 6p is predictive of the transformation of follicular lymphoma (Q34707259) (← links)
- Risk of non-Hodgkin lymphoma associated with germline variation in genes that regulate the cell cycle, apoptosis, and lymphocyte development (Q34972303) (← links)
- Host genetics in follicular lymphoma (Q35038312) (← links)
- A comprehensive evaluation of the role of genetic variation in follicular lymphoma survival (Q35311162) (← links)
- Risk factors of non-Hodgkin's lymphoma (Q35499320) (← links)
- Polymorphisms in immune function genes and non-Hodgkin lymphoma survival (Q35889753) (← links)
- Risk Factors of Follicular Lymphoma (Q36062546) (← links)
- Inherited Inflammatory Response Genes Are Associated with B-Cell Non-Hodgkin's Lymphoma Risk and Survival (Q36137122) (← links)
- Leveraging epidemiology and clinical studies of cancer outcomes: recommendations and opportunities for translational research (Q36535678) (← links)
- Tumor necrosis factor-308 polymorphism with the risk and prognosis of non-Hodgkin lymphomas: a meta-analysis study (Q36729256) (← links)
- Host immune gene polymorphisms in combination with clinical and demographic factors predict late survival in diffuse large B-cell lymphoma patients in the pre-rituximab era (Q36915855) (← links)
- Follicular lymphoma B cells induce the conversion of conventional CD4 T cells to T-regulatory cells (Q37073655) (← links)
- Human B cell subsets (Q37260869) (← links)
- Refining the treatment of follicular lymphoma (Q37280919) (← links)
- Genetic variation in B-cell-activating factor is associated with an increased risk of developing B-cell non-Hodgkin lymphoma (Q37345560) (← links)
- Predicting transformation in follicular lymphoma (Q37552778) (← links)
- Genetic variations as cancer prognostic markers: review and update (Q37565360) (← links)
- Do recent reports of prolonged survival in patients with follicular lymphoma suggest that deferral of therapy is no longer justifiable? (Q37738494) (← links)
- Prognostic biomarkers in malignant lymphomas (Q37775634) (← links)
- The Basis and Rational Use of Molecular Genetic Testing in Mature B-cell Lymphomas (Q37781972) (← links)
- Prognostic tools in follicular lymphomas (Q37810119) (← links)
- Host Factors for Risk and Survival in Lymphoma (Q37829223) (← links)
- The secret ally: immunostimulation by anticancer drugs (Q37981038) (← links)
- Interleukin-12: clinical usage and molecular markers of cancer susceptibility. (Q38003641) (← links)
- The tumour microenvironment in B cell lymphomas (Q38227748) (← links)
- Genome-wide genotype-based risk model for survival in acute myeloid leukaemia patients with normal karyotype. (Q38445540) (← links)
- Inherited variation in immune response genes in follicular lymphoma and diffuse large B-cell lymphoma (Q38516259) (← links)
- Follicular lymphomas and their transformation: Past and current research. (Q39290214) (← links)
- Advanced-stage follicular lymphoma in the rituximab era: when should patients receive anthracycline-based chemotherapy? (Q39950688) (← links)
- Genetic Variations of Tumor Necrosis Factor -α-308 and Lymphtoxin-α 252 in Non-Hodgkin Lymphoma and Acute Lymphoblastic Leukemia Patients (Q41854152) (← links)
- IL12 polymorphisms, HBV infection and risk of hepatocellular carcinoma in a high-risk Chinese population. (Q42997493) (← links)
- Impact of Polymorphic Variations of Gemcitabine Metabolism, DNA Damage Repair, and Drug-Resistance Genes on the Effect of High-Dose Chemotherapy for Relapsed or Refractory Lymphoid Malignancies (Q47102782) (← links)
- Human leukocyte antigen class I and II alleles and overall survival in diffuse large B-cell lymphoma and follicular lymphoma. (Q53202453) (← links)